S38 Hyperinsulinism in Infancy and Childhood

Program: Symposia
Clinical/Translational Session
Saturday, April 2, 2016: 4:45 PM-6:15 PM
Room 210 (BCEC)
Chair:
Charles A Stanley, MD, The Children's Hospital of Philadelphia, Philadelphia, PA

Nothing to Disclose: CAS
4:45 PM
Sian Ellard, PhD, FRCPath, Human Molecular Genetics, University of Exeter Medical School, United Kingdom
Nothing to Disclose: SE
5:15 PM
Diva Del Carmen De Leon-Crutchlow, MD, MSCE, Pediatrics, Children's Hospital of Philadelphia, Philadelphia, PA
Nothing to Disclose: DDCD
5:45 PM
Khalid Hussain, MBChB, MRCP, MD, MSc, MRCPCH, Genetic and Genomic Medicine Programme, UCL Institute of Child Health/Great Ormond Street Hospital, London, United Kingdom
Nothing to Disclose: KH
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire